Tango Therapeutics Inc (TNGO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2011 | 09-2011 | 06-2011 | 03-2011 | 12-2010 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 43,407 | 52,521 | 8,981 | 6,876 | 5,913 |
| Receivables | 25,311 | 24,405 | 21,007 | 20,191 | 14,295 |
| TOTAL | $71,221 | $79,024 | $31,406 | $28,556 | $21,603 |
| Non-Current Assets | |||||
| PPE Net | 3,334 | 2,578 | 2,610 | 2,508 | 1,795 |
| Intangibles | 65,066 | 43,803 | 44,576 | 43,762 | 33,421 |
| Other Non-Current Assets | 1,241 | 1,070 | 3,744 | 2,727 | 1,925 |
| TOTAL | $69,641 | $47,451 | $50,930 | $48,997 | $37,141 |
| Total Assets | $140,862 | $126,475 | $82,336 | $77,553 | $58,744 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 6,605 | 6,439 | 5,894 | 4,434 | 3,303 |
| Accrued Expenses | 7,061 | 4,961 | 5,367 | 4,544 | 3,364 |
| Other current liabilities | 1,079 | 766 | N/A | N/A | N/A |
| TOTAL | $31,700 | $24,976 | $30,308 | $27,382 | $21,316 |
| Non-Current Liabilities | |||||
| Long Term Debt | 8,290 | 3,762 | 21,170 | 22,028 | 11,777 |
| Deferred Revenues | 9,051 | 9,252 | 8,492 | 8,973 | 8,304 |
| Other Non-Current Liabilities | 0 | 0 | 67,408 | 64,988 | 62,786 |
| TOTAL | $12,573 | $7,874 | $91,385 | $92,695 | $79,450 |
| Total Liabilities | $44,273 | $32,850 | $121,693 | $120,077 | $100,766 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 34,297 | 32,963 | 32,735 | 4,834 | 23,896 |
| Common Shares | 3 | 3 | N/A | 1 | N/A |
| Retained earnings | -56,795 | -57,698 | -55,528 | -53,193 | -51,635 |
| Other shareholders' equity | 10,476 | 10,482 | 6,819 | 2,291 | 2,296 |
| TOTAL | $96,589 | $93,625 | $-39,357 | $-42,524 | $-42,022 |
| Total Liabilities And Equity | $140,862 | $126,475 | $82,336 | $77,553 | $58,744 |